164 related articles for article (PubMed ID: 26026093)
1. Microarray Gene-expression Profiling Analysis Comparing PCNSL and Non-CNS Diffuse Large B-Cell Lymphoma.
Lim DH; Kim WS; Kim SJ; Yoo HY; Ko YH
Anticancer Res; 2015 Jun; 35(6):3333-40. PubMed ID: 26026093
[TBL] [Abstract][Full Text] [Related]
2. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.
Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R
Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345
[TBL] [Abstract][Full Text] [Related]
3. Pathway analysis of primary central nervous system lymphoma.
Tun HW; Personett D; Baskerville KA; Menke DM; Jaeckle KA; Kreinest P; Edenfield B; Zubair AC; O'Neill BP; Lai WR; Park PJ; McKinney M
Blood; 2008 Mar; 111(6):3200-10. PubMed ID: 18184868
[TBL] [Abstract][Full Text] [Related]
4. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
5. Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.
Deckert M; Montesinos-Rongen M; Brunn A; Siebert R
Acta Neuropathol; 2014 Feb; 127(2):175-88. PubMed ID: 24240734
[TBL] [Abstract][Full Text] [Related]
6. Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.
Lemma SA; Kuusisto M; Haapasaari KM; Sormunen R; Lehtinen T; Klaavuniemi T; Eray M; Jantunen E; Soini Y; Vasala K; Böhm J; Salokorpi N; Koivunen P; Karihtala P; Vuoristo J; Turpeenniemi-Hujanen T; Kuittinen O
Carcinogenesis; 2017 Aug; 38(8):812-820. PubMed ID: 28854563
[TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities.
De Paepe P; De Wolf-Peeters C
Leukemia; 2007 Jan; 21(1):37-43. PubMed ID: 17039226
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell.
Montesinos-Rongen M; Brunn A; Bentink S; Basso K; Lim WK; Klapper W; Schaller C; Reifenberger G; Rubenstein J; Wiestler OD; Spang R; Dalla-Favera R; Siebert R; Deckert M
Leukemia; 2008 Feb; 22(2):400-5. PubMed ID: 17989719
[TBL] [Abstract][Full Text] [Related]
9. Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
Fischer L; Hummel M; Korfel A; Lenze D; Joehrens K; Thiel E
Neuro Oncol; 2011 Oct; 13(10):1090-8. PubMed ID: 21803762
[TBL] [Abstract][Full Text] [Related]
10. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression.
Yuan J; Gu K; He J; Sharma S
Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.
Akhter A; Masir N; Elyamany G; Phang KC; Mahe E; Al-Zahrani AM; Shabani-Rad MT; Stewart DA; Mansoor A
J Neurooncol; 2015 Jan; 121(2):289-96. PubMed ID: 25391967
[TBL] [Abstract][Full Text] [Related]
12. Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
Lemma SA; Pasanen AK; Haapasaari KM; Sippola A; Sormunen R; Soini Y; Jantunen E; Koivunen P; Salokorpi N; Bloigu R; Turpeenniemi-Hujanen T; Kuittinen O
Eur J Haematol; 2016 May; 96(5):492-501. PubMed ID: 26153511
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of primary vitreoretinal lymphoma.
Arai A; Takase H; Yoshimori M; Yamamoto K; Mochizuki M; Miura O
Cancer Sci; 2020 Apr; 111(4):1417-1421. PubMed ID: 32056332
[TBL] [Abstract][Full Text] [Related]
14. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
Booman M; Szuhai K; Rosenwald A; Hartmann E; Kluin-Nelemans H; de Jong D; Schuuring E; Kluin P
J Pathol; 2008 Oct; 216(2):209-17. PubMed ID: 18729069
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features of primary diffuse large B-cell lymphoma of the central nervous system - strong EZH2 expression implying diagnostic and therapeutic implication.
Guo S; Bai Q; Rohr J; Wang Y; Liu Y; Zeng K; Yu K; Zhang X; Wang Z
APMIS; 2016 Dec; 124(12):1054-1062. PubMed ID: 27807891
[TBL] [Abstract][Full Text] [Related]
16. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
[TBL] [Abstract][Full Text] [Related]
17. SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts.
Sugita Y; Tokunaga O; Nakashima A; Shigemori M
Pathol Int; 2004 Sep; 54(9):659-66. PubMed ID: 15363033
[TBL] [Abstract][Full Text] [Related]
18. Gene expression and angiotropism in primary CNS lymphoma.
Rubenstein JL; Fridlyand J; Shen A; Aldape K; Ginzinger D; Batchelor T; Treseler P; Berger M; McDermott M; Prados M; Karch J; Okada C; Hyun W; Parikh S; Haqq C; Shuman M
Blood; 2006 May; 107(9):3716-23. PubMed ID: 16418334
[TBL] [Abstract][Full Text] [Related]
19. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system.
Arai M; Sasaki A; Saito N; Nakazato Y
Pathol Int; 2005 Mar; 55(3):122-9. PubMed ID: 15743320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
